Company page

Artelo Biosciences, Inc.

Artelo Biosciences, Inc. is a public company traded under the ticker ARTL in the American market. The company has a market capitalization of approximately $3.56 million. Artelo focuses on developing innovative therapies, particularly in the field of cannabinoid-based treatments.